Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2022-06-30
2024-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* do appropriate referrals increase for patients using the new screener?
* do appropriate diagnostic orders increase for patients using the new screener? Participants will respond to 4 questions about their cognitive abilities as part of a larger AWV protocol.
Researchers will compare provider behavior for patients completing AWVs before and after implementation of the new screener to see if referral, diagnostic and prescribing behaviors differ.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Assessment of Elderly Primary Care Patients
NCT01492335
Caregiver Outcomes of Alzheimer's Disease Screening
NCT03300180
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
NCT04852601
Assessing Cognitive Decline at Home
NCT06704971
Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease
NCT06856681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
new screener group
patients completing annual wellness visits after the new screener is adopted by the UPMC health system
PRO-CS
4 questions about cognitive function added to annual wellness visit protocol
pre screener group
patients completing annual wellness visits before the new screener is adopted by the UPMC health system
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PRO-CS
4 questions about cognitive function added to annual wellness visit protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
University of Pittsburgh Medical Center
OTHER
Northwestern University
OTHER
RAND
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Edelen, PhD
Role: PRINCIPAL_INVESTIGATOR
RAND
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburg Medical Center
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCQMI065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.